2830
G. Villorbina et al. / Tetrahedron Letters 50 (2009) 2828–2830
0.87 (t, J = 6.9 Hz, 3H, CH3). 13C RMN (CDCl3), d: 173.0 (C@O), 71.7 (O–CH), 42.7
(CH2–Cl), 34.4 (CH2 ( ) (C@O)), 32.2 (CH2–CH2–CH3), 29.9, 29.8, 29.7, 29.6, 29.4,
1,3-Dichloro-2-propyl 3-nitrobenzoate (3 m): 1H NMR (CDCl3), d: 8.87 (s, 1H,
CHar), 8.42 (dd, J1 = 25.0 Hz, J2 = 8.2 Hz, 2H, CHar), 7.69 (t, J = 8.2 Hz, 1H, CHar),
5.48 (quin, J = 5.1 Hz, 1H, O–CH), 3.90 (d, J = 5.5 Hz, 4H, 2 CH2–Cl). 13C RMN
(CDCl3), d: 163.8 (C@O), 151.1 (Car–NO2), 134.7 (Car–C@O), 130, 129.8, 122.7
(CHar), 73.3 (O–CH), 42.5 (CH2–Cl).
a
29.3 (CH2), 25.1 (CH2
(C@O)), 22.9 (CH2-CH3), 14.4 (CH3). HRMS (EI+)
(b)
calculated for C11H20O2Cl2: 352.1936. Found: 352.1932.
1,3-Dichloro-2-propyl laureate (3d): 1H NMR (CDCl3), d: 5.18 (quin, J = 5.2 Hz,
1H, O–CH), 3.73 (dd, J1 = 5.4 Hz, J2 = 2 Hz, 4H, 2 CH2–Cl), 2.37 (t, J = 7 Hz, 2H,
1,3-Dichloro-2-propyl 3,5-dinitrobenzoate (3n): 1H NMR (COCD6), d: 9.17 (t,
J = 2.1 Hz 1H, CHar), 9.10 (d, J = 2.1 Hz, 2H, CHar), 5.67 (quin, J = 5.1 Hz, 1H, O–
CH), 4.11 (d, J = 5.1 Hz, 4H, CH2–Cl). 13C RMN (COCD6), d: 164.4 (C@O), 149.1
(Car–NO2), 134.3 (Car–C@O), 128.0, 122.8 (CHar), 76.3 (O–CH), 43.5 (CH2–Cl).
1,3-Dichloro-2-propyl 1-naphthoate (3o): 1H NMR (CDCl3), d: 8.93 (dd,
J1 = 8.8 Hz, J2 = 0.8 Hz, 1H, CHar), 8.28 (dd, J1 = 7.6 Hz, J2 = 1.6 Hz, 1H, CHar),
8.07 (d, J = 8.4 Hz, 1H, CHar), 7.91 (d, J = 7.6 Hz, 1H, CHar), 7.65 (m, 1H, CHar),
7.54 (m, 2H, 2 CHar), 5.54 (quin, J = 4.8 Hz, 1H, O–CH), 3.96 (d, J = 4.8 Hz, 4H, 2
CH2–Cl). 13C RMN (CDCl3), d: 166.3 (C@O), 134.4, 134.1, 131.6, 131.2, 128.9,
128.4, 126.6, 125.9, 125.8, 124.8 (CHar), 72.4 (O–CH), 42.8 (CH2–Cl).
1,3-Dichloro-2-propyl 2-naphthoate (3p): 1H NMR (CDCl3), d: 8.58 (s, 1H, CHar),
8.01 (dd, J1 = 8.8 Hz, J2 = 1.6 Hz, 1H, CHar), 7.92 (d, J = 8.4 Hz, 1H, CHar), 7.84 (d,
J = 8.8 Hz, 1H, CHar), 7.83 (d, J = 8 Hz, 1H, CHar), 7.53 (m, 2H, 2 CHar), 5.44 (quin,
J = 4.8 Hz, 1H, O–CH), 3.88 (d, J = 4.8 Hz, 4H, 2 CH2–Cl). 13C RMN (CDCl3), d:
165.8 (C@O), 136.0, 132.7, 131.9, 129.7, 128.9, 128.6, 128.0, 127.1, 126.6, 125.4
(CHar), 72.4 (O–CH), 42.7 (CH2–Cl).
CH2 ( ) (C@O)), 1.65 (m, 2H, CH2 (b) (C@O)), 1.26 (m, 24H, CH2), 0.88 (t, J = 7 Hz,
a
3H, CH3). 13C RMN (CDCl3), d: 173.0 (C@O), 71.7 (O–CH), 42.7 (CH2–Cl), 34.3
(CH2
(CH2
(C@O)), 32.1 (CH2–CH2–CH3), 29.8, 29.6, 29.5, 29.4, 29.3, (CH2), 25.1
(C@O)), 22.9 (CH2-CH3), 14.3 (CH3).
(a)
(b)
1,3-Dichloro-2-propyl caprylate (3e): 1H NMR (CDCl3), d: 5.12 (quin, J = 5.1 Hz,
1H, O–CH), 3.74 (dd, J1 = 5.5 Hz, J2 = 2.0 Hz, 4H, 2 CH2–Cl), 2.34 (t, J = 7.8 Hz, 2H,
CH2 ( ) (C@O)), 1.63 (quin, J = 7.4 Hz, 2H, CH2 (b) (C@O)), 1.29 (m, 8H, CH2), 0.87
a
(t, J = 7.0 Hz, 3H, CH3). 13C RMN (CDCl3), d: 173.0 (C@O), 72.0 (O–CH), 42.0
(CH2–Cl), 34.4 (CH2
(C@O)), 32.1 (CH2–CH2–CH3), 29.5 (CH2), 25.0 (CH2
(
a
)
(b)
(C@O)), 22.5 (CH2-CH3), 14.5 (CH3).
1,3-Dichloro-2-propyl 2-furoate (3f): 1H NMR (CDCl3), d: 7.62 (m, CHar), 7.26 (dt,
J1 = 3.5 Hz, J2 = 0.8 Hz, 1H, CHar), 6.53 (m, 1H, CHar), 5.39 (quin, J = 5.1 Hz, 1H,
O–CH), 3.85 (d, J = 5.6 Hz, 4H, CH2–Cl). 13C RMN (CDCl3), d: 156.9 (C@O), 146.5
(CHar), 143.7 (CHar–C@O), 119.8, 112.1 (CHar), 72.3 (O–CH), 43.1 (CH2–Cl).
1,3-Dichloro-2-propyl 2-thiophencarboxylate (3g): 1H NMR (CDCl3), d: 7.79 (dd,
J1 = 3.9 Hz, J2 = 1.2 Hz, 1H, CHar), 7.55 (dd, J1 = 5.1 Hz, J2 = 1.2 Hz, 1H, CHar), 7.06
(dd, J1 = 5.0 Hz, J2 = 3.9 Hz, 1H, CHar), 5.31 (quin, J = 5.1 Hz, 1H, O–CH), 3.80 (d,
J = 5.1 Hz, 4H, CH2–Cl). 13C RMN (CDCl3), d: 161.1 (C@O), 144.8 (CHar), 143.8
(CHar–C@O), 122.5, 118.1 (CHar), 72.2 (O–CH), 42.8 (CH2–Cl).
7. Experimental procedure.
A mixture of palmitic acid (1 mequiv), glycerol
(2 mequiv), Crown-18 ether (0.125 mequiv, 10% mol), potassium chloride
(5 mequiv) and [BMIM][PF6] (2.5 g) was stirred in a 10-mL reactor for 48 h at
100 °C. The crude reaction mixture was extracted with hexane (3 Â 2 mL) while
stirring in a circular shaker placed into an oven for 30 min at 40 °C. The upper
phase was recovered and dried over anhydrous sodium sulfate. Organic
solution was filtered and evaporated to dryness. Yield was determined using 1H
NMR with 1,4-dichlorobenzene13 as internal standard.
1,3-Dichloro-2-propyl benzoate (3h): 1H NMR (CDCl3), d: 8.00 (m, 1H, CHar
(a)
(C@O)), 7.53 (m, 1H, CHar), 7.39 (m, 2H, CHar), 5.36 (quin, J = 5.3 Hz, 1H, O–CH),
3.82 (m, 4H, 2 CH2–Cl). 13C RMN (CDCl3), d: 163.4 (C@O), 131.7,127.9, 127.2,
126.6 (Car), 70.1 (O–CH), 40.5 (CH2–Cl).
1,3-Dichloro-2-propyl cinnamate (3i): 1H NMR (CDCl3), d: 7.73 (d, J = 15.6 Hz,
1H, CHar), 7.48 (m, 2H, 2 CHar), 7.34 (m, 3H, 2 CHar, Ph–CH@CH), 6.41 (m, 1H,
Ph–CH@CH), 5.25 (quin, J = 5.1 Hz, 1H, O–CH), 3.76 (d, J = 5.5 Hz, 4H, 2 CH2–Cl).
13C RMN (CDCl3), d: 165.9 (C@O), 146.7 (Ph–CH@CH), 134.2 (Car), 130.9, 129.2,
128.5 (CHar), 117.0 (Ph–CH@CH), 71.9 (O–CH), 42.7 (CH2–Cl).
1,3-Dichloro-2-propyl palmitate (3a): 1H NMR (CDCl3), d: 5.18 (quin, J = 5.2 Hz,
1H, O–CH), 3.73 (m, 4H, 2 CH2–Cl), 2.37 (t, J = 7 Hz, 2H, CH2 ( ) (C@O)), 1.65 (m,
a
2H, CH2
(C@O)), 1.26 (m, 24H, CH2), 0.88 (t, J = 7 Hz, 3H, CH3). 13C RMN
(b)
(CDCl3), d: 172.7 (C@O), 71.5 (O–CH), 42.5 (CH2–Cl), 34.1 (CH2
(C@O)), 31.9
(a)
(CH2–CH2–CH3), 29.7, 29.6, 29.5, 29.4, 29.3, 29.2, 29.0 (CH2), 24.8 (CH2
(C@O)), 22.7 (CH2–CH3), 14.1 (CH3).
(b)
1,3-Dichloro-2-propyl salicylate (3j): 1H NMR (CDCl3), d: 7.81 (dd, J1 = 8.2 Hz,
J2 = 1.7 Hz, 1H, CHar), 7.50 (m, 1H, CHar), 6.95 (d, J = 7.5 Hz, 1H, CHar), 6.80 (m,
8. (a) Pews, R. G.; Davis, R. A. Chem. Commun. 1973, 269; (b) Derbesy, M.; Naudet,
M. Bull. Soc. Chim. France 1968, 4531–4539; (c) Nayler, J. H. C. J. Chem. Soc. 1959,
189–195.
9. Méndez, J. J.; Eras, J.; Balcells, M.; Canela, R. Synth. Commun. 2006, 36, 1167–
1175.
10. D’Anna, F.; La Marca, S.; Noto, R. J. Org. Chem. 2008, 73, 3397–3403.
11. Yau, H. M.; Barnes, S. A.; Hook, J. M.; Youngs, T. G. A.; Croft, A. K.; Harper, J. B.
Chem. Commun. 2008, 3576–3578.
12. Chiappe, C. In Ionic Liquids in Synthesis; Welton, T., Wasserscheid, P., Eds.; Ionic
Liquids in Organic Synthesis: Effects on Rate and Selectivity; Wiley-VCH:
Wheinheim, 2007; pp 265–292.
1H, CHar), 5.39 (quin, J = 5.1 Hz, 1H, O–CH), 3.82 (d, J = 5.5 Hz, 4H, 2 CH2–Cl). 13
C
RMN (CDCl3), d: 169.1 (C@O), 162.1 (Car-OH), 136.7, 130.3, 119.7, 117.9, 111.8
(CHar), 72.7 (O–CH), 42.5 (CH2–Cl).
1,3-Dichloro-2-propyl 2-chlorobenzoate (3k): 1H NMR (CDCl3), d: 7.88 (m, 1H,
CHar), 7.47 (td, J1 = 7.8 Hz, J2 = 1.6 Hz, 2H, CHar), 7.35 (m, 1H, CHar), 5.44 (quin,
J = 5.2 Hz, 1H, O-CH), 3.89 (d, J = 5.5 Hz, 4H, 2 CH2–Cl). 13C RMN (CDCl3), d:
164.5 (C@O), 134.4 (Car–OH), 133.4, 131.9, 131.5, 129.1, 126.9 (Car), 72.9 (O–
CH), 42.5 (CH2–Cl).
1,3-Dichloro-2-propyl 3-aminobenzoate (3 l): 1H NMR (CDCl3), d: 5.38 (quin,
J = 5.0 Hz, 1H, O–CH), 3.90 (d, 4H, J = 5.1 Hz, 2 CH2–Cl). 13C RMN (MeOD), d:
166.1 (C@O), 148.4 (Car-NH2), 130.1 (Car-C@O), 129.0, 119.9, 118.8, 115.7
(CHar), 72.6 (O–CH), 42.6 (CH2–Cl). HRMS (EI+) calculated for C11H20O2Cl2:
247.0167. Found: 247.0162.
13. Main, K. B.; Medwick, T.; Bailey, L. C.; Shinkai, J. H. Pharm. Res. 1987, 4, 412–
415.